The CycloGen AI Discovery Pipeline

From target to candidate — accelerated by AI, powered by local GPUs, and deployed entirely within your infrastructure. CycloGen AI delivers secure, end-to-end molecular discovery without compromising data ownership or control.

1

Target Structure

Import or predict protein structures using integrated AI engines.

2

Pocket Detection

Identify druggable binding sites and structural hotspots.

3

Molecule Generation

Generate ligands, peptides, minibinders, and biologics.

4

Docking & Scoring

GPU-accelerated docking with AI affinity scoring.

5

Lead Optimization

Rank candidates by stability, affinity, and drug-likeness.

6

Candidate Selection

Export high-confidence candidates for wet-lab validation.

Why On-Prem AI Changes the Game

Most AI Drug Discovery Platforms

  • ✖ Cloud-only architecture
  • ✖ API-dependent workflows
  • ✖ Not deployable in secure biotech environments
  • ✖ Limited by vendor GPU capacity
  • ✖ Data leaves your infrastructure
  • ✖ Roadmap controlled by external vendors

CycloGen AI — Fully On-Prem

  • ✔ Local inference
  • ✔ Local GPU execution
  • ✔ API only as fallback
  • ✔ Fully deployable in secure environments
  • ✔ Complete data ownership
  • ✔ Infrastructure-level control

You are not buying a SaaS tool. You are acquiring a sovereign AI capability.

A Strategic Advantage for Pharma & CROs

Avoid Data-Security Risks
Eliminate Vendor Lock-In
No API Rate Limits
Reduce Cloud Compute Costs
Scale Internally
Integrate Deeply Into Pipelines

You Don't Just Use AI. You Own It.

CycloGen AI gives your organization full control over discovery, data, and deployment.

Request Enterprise Demo